发表论文
[1] Liu, Pei, Gao, Youshui, Luo, Pengbo, Yu, Hongping, Guo, Shang, Liu, Fuyun, Gao, Junjie, Xu, Jianzhong, Wang, Shengdian, Zhang, Changqing. Glucocorticoid-induced expansion of classical monocytes contributes to bone loss. EXPERIMENTAL AND MOLECULAR MEDICINE[J]. 2022, 第 9 作者 通讯作者 54(6): 765-776, http://dx.doi.org/10.1038/s12276-022-00764-6.[2] Jianli He, Xun Shangguan, Wei Zhou, Ying Cao, Quan Zheng, Jun Tu, Gaolei Hu, Zi Liang, Cen Jiang, Liufu Deng, Shengdian Wang, Wen Yang, Yong Zuo, Jiao Ma, Rong Cai, Yalan Chen, Qiuju Fan, Baijun Dong, Wei Xue, Hongsheng Tan, Yitao Qi, Jianmin Gu, Bing Su, Y Eugene Chin, Guoqiang Chen, Qi Wang, Tianshi Wang, Jinke Cheng. Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development. NATURE COMMUNICATIONS[J]. 2021, 第 11 作者12(1): http://dx.doi.org/10.1038/s41467-021-24619-2.[3] Liu, Lei, Zheng, Yaqiong, Cai, Liping, Wu, Wanlei, Tang, Shi, Ding, Yinjuan, Liu, Wanbing, Kou, Guomei, Xiong, Zhou, Wang, Shengdian, Zheng, Shangen. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY[J]. 2021, 第 10 作者 通讯作者 43(2): 329-335, http://dx.doi.org/10.1111/ijlh.13374.[4] Li, Tiepeng, Zhao, Lingdi, Yang, Yonghao, Wang, Yao, Zhang, Yong, Guo, Jindong, Chen, Guangyu, Qin, Peng, Xu, Benling, Ma, Baozhen, Zhang, Fang, Shang, Yiman, Li, Qingjun, Zhang, Kai, Yuan, Dongfeng, Feng, Chaojie, Ma, Yan, Liu, Zhiyong, Tian, Zhichao, Li, Hongle, Wang, Shengdian, Gao, Quanli. T Cells Expanded from PD-1(+) Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating Lymphocytes. CANCER RESEARCH[J]. 2021, 第 21 作者81(8): 2184-2194, http://dx.doi.org/10.1158/0008-5472.CAN-20-2300.[5] Ying Li, Yanni Cong, Mingming Jia, Qianqian He, Haiqing Zhong, Yun Zhao, Hang Li, Meining Yan, Jia You, Jia Liu, Lieping Chen, Haiying Hang, Shengdian Wang. Targeting IL-21 to tumor-reactive T cells enhances memory T cell responses and anti-PD-1 antibody therapy. NATURE COMMUNICATIONS[J]. 2021, 第 13 作者 通讯作者 12(1): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878483/.[6] Wang, Xiang, Qiu, Zhiqiang, Ji, Xiangwen, Ning, Weihai, An, Yihua, Wang, Shengdian, Zhang, Hongwei. A novel workflow for cancer blood biomarker identification. ANNALS OF TRANSLATIONAL MEDICINE[J]. 2020, 第 6 作者8(21): http://dx.doi.org/10.21037/atm-20-2047.[7] Ning, Weihai, Qiu, Zhiqiang, Ji, Xiangwen, Wang, Xiang, An, Yihua, Wang, Shengdian, Zhang, Hongwei. The Prognostic Value of EMT in Glioma and its Role in the Glioma Immune Microenvironment. JOURNAL OF MOLECULAR NEUROSCIENCE[J]. 2020, 第 6 作者70(10): 1501-1511, http://dx.doi.org/10.1007/s12031-020-01583-y.[8] Lu, Shuangshuang, Zhang, Zhe, Du, Pan, Chard, Louisa S, Yan, Wenli, El Khouri, Margueritte, Wang, Zhizhong, Zhang, Zhongxian, Chu, Yongchao, Gao, Dongling, Zhang, Qinxian, Zhang, Lirong, Nagano, Ai, Wang, Jun, Chelala, Claude, Liu, Jing, Chen, Jiekai, Liu, Pentao, Dong, Yunshu, Wang, Shengdian, Li, Xiaozhu, Dong, Jianzeng, Lemoine, Nick R, Pei, Duanqing, Wang, Yaohe. A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer. CLINICAL CANCER RESEARCH[J]. 2020, 第 20 作者26(2): 465-476, http://dx.doi.org/10.1158/1078-0432.CCR-19-1395.[9] Liu, Lei, Liu, Wanbing, Zheng, Yaqiong, Jiang, Xiaojing, Kou, Guomei, Ding, Jinya, Wang, Qiongshu, Huang, Qianchuan, Ding, Yinjuan, Ni, Wenxu, Wu, Wanlei, Tang, Shi, Tan, Li, Hu, Zhenhong, Xu, Weitian, Zhang, Yong, Zhang, Bo, Tang, Zhongzhi, Zhang, Xinhua, Li, Honghua, Rao, Zhiguo, Jiang, Hui, Ren, Xingfeng, Wang, Shengdian, Zheng, Shangen. A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients. MICROBES AND INFECTION[J]. 2020, 第 24 作者 通讯作者 22(4-5): 206-211, http://dx.doi.org/10.1016/j.micinf.2020.05.008.[10] Fan, Ying, Li, Shu, Ding, Xiaoyan, Yue, Jian, Jiang, Jun, Zhao, Hong, Hao, Rui, Qiu, Weiliang, Liu, Kezhen, Li, Ying, Wang, Shengdian, Zheng, Limin, Ye, Bin, Meng, Kun, Xu, Binghe. First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers. BMC CANCER[J]. 2019, 第 11 作者19(1): https://doaj.org/article/e5def464c08b4bc7a24691f63732eb8e.[11] Xu, Benling, Yuan, Long, Chen, Guangyu, Li, Tiepeng, Zhou, Jinxue, Zhang, Chengjuan, Qin, Peng, Muthana, Musleh M, Wang, Shengdian, Du, Xuexiang, Gao, Quanli. S-15 in combination of Akt inhibitor promotes the expansion of CD45RA(-)CCR7(+) tumor infiltrating lymphocytes with high cytotoxic potential and downregulating PD-1(+)Tim-3(+) cells as well as regulatory T cells. CANCER CELL INTERNATIONAL[J]. 2019, 第 9 作者 通讯作者 19(1): http://dx.doi.org/10.1186/s12935-019-1043-3.[12] Chao Zhang, Xiaomei Wang, Shuran Li, Trix Twelkmeyer, Weihong Wang, Shengyuan Zhang, Shufeng Wang, Jizheng Chen, Xia Jin, Yuzhang Wu, Xinwen Chen, Shengdian Wang, Junqi Niu, Hairong Chen, Hong Tang. NKG2A is a NK cell exhaustion checkpoint for HCV persistence. NATURE COMMUNICATIONS[J]. 2019, 第 12 作者10(1): 1-11, http://www.corc.org.cn/handle/1471x/2373162.[13] Wang, Pengju, Li, Xiaozhu, Wang, Jiwei, Gao, Dongling, Li, Yuenan, Li, Haoze, Chu, Yongchao, Zhang, Zhongxian, Liu, Hongtao, Jiang, Guozhong, Cheng, Zhenguo, Wang, Shengdian, Dong, Jianzeng, Feng, Baisui, Chard, Louisa S, Lemoine, Nicholas R, Wang, Yaohe. Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent (vol 8, 2017). NATURE COMMUNICATIONS. 2018, 第 12 作者9: https://www.webofscience.com/wos/woscc/full-record/WOS:000419677600001.[14] Wang, Conghui, Cheng, Yuqiang, Zhang, Xiuping, Li, Nan, Zhang, Lin, Wang, Shengdian, Tong, Xuemei, Xu, Ying, Chen, Guoqiang, Cheng, Shuqun, Fan, Xuemei, Liu, Junling. Vacuolar Protein Sorting 33B Is a Tumor Suppressor in Hepatocarcinogenesis. HEPATOLOGY[J]. 2018, 第 6 作者68(6): 2239-2253, https://www.webofscience.com/wos/woscc/full-record/WOS:000451622600058.[15] Li, Dongling, Hu, Minling, Liu, Ying, Ye, Peiying, Du, Peishuang, Li, ChiShan, Cheng, Liang, Liu, Ping, Jiang, Jing, Su, Lishan, Wang, Shengdian, Zheng, Pan, Liu, Yang. CD24-p53 axis suppresses diethylnitrosamine-induced hepatocellular carcinogenesis by sustaining intrahepatic macrophages. CELL DISCOVERY[J]. 2018, 第 11 作者4(1): https://doaj.org/article/87186af3194a41d18b0cef851952576f.[16] 王盛典. CD24-p53 axis suppresses diethylnitrosamine-induced hepatocellylar carcinogenesis by sustaining intrahepatic macrophages. Cell Discov. 2018, 第 1 作者[17] Zhang, Jinhua, Song, Kun, Wang, Jun, Li, Yanan, Liu, Shuangqing, Dai, Chengliang, Chen, Lieping, Wang, Shengdian, Qin, Zhihai. S100A4 blockage alleviates agonistic anti-CD137 antibody-induced liver pathology without disruption of antitumor immunity. ONCOIMMUNOLOGY[J]. 2018, 第 8 作者7(4): https://doaj.org/article/868c19de8a3844e29ad6c0ca3f084355.[18] Wang, LiXin, Chen, Xiaoping, Jia, Mingming, Wang, Shengdian, Shen, Jianliang. Arthritis of large joints shown as a rare clinical feature of cytokine release syndrome after chimeric antigen receptor T cell therapy A case report. MEDICINE[J]. 2018, 第 4 作者97(16): https://www.webofscience.com/wos/woscc/full-record/WOS:000431517200040.[19] Nie, Xinxin, Chen, Wenni, Zhu, Ying, Huang, Baozhu, Yu, Weiwei, Wu, Zhanshuai, Guo, Sizheng, Zhu, Yiping, Luo, Liqun, Wang, Shengdian, Chen, Lieping. B7-DC (PD-L2) costimulation of CD4(+) T-helper 1 response via RGMb. CELLULAR & MOLECULAR IMMUNOLOGY[J]. 2018, 第 10 作者15(10): 888-897, https://www.webofscience.com/wos/woscc/full-record/WOS:000448672300004.[20] Li, Xiaozhu, Wang, Pengju, Li, Hang, Du, Xuexiang, Liu, Mingyue, Huang, Qibin, Wang, Yaohe, Wang, Shengdian. The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model. CLINICAL CANCER RESEARCH[J]. 2017, 第 8 作者 通讯作者 23(1): 239-249, https://www.webofscience.com/wos/woscc/full-record/WOS:000393876300027.[21] Pengju Wang, Xiaozhu Li, Jiwei Wang, Dongling Gao, Yuenan Li, Haoze Li, Yongchao Chu, Zhongxian Zhang, Hongtao Liu, Guozhong Jiang, Zhenguo Cheng, Shengdian Wang, Jianzeng Dong, Baisui Feng, Louisa S Chard, Nicholas R Lemoine, Yaohe Wang. Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent. NATURE COMMUNICATIONS[J]. 2017, 第 12 作者8(1): https://doaj.org/article/d991a41699f34b37801c9116d53e2378.[22] 王盛典. Re-designing interluekin-12 to enhancs its safety and potential as an anti-tumor immunothreapeutic agent. Nat Commun. 2017, 第 1 作者[23] Yang, Zuyu, Jia, Mingming, Liu, Guojing, Hao, Huaining, Chen, Li, Li, Guanghao, Liu, Sixue, Li, Yawei, Wu, ChungI, Lu, Xuemei, Wang, Shengdian. Genomic sequencing identifies a few mutations driving the independent origin of primary liver tumors in a chronic hepatitis murine model. PLOS ONE[J]. 2017, 第 11 作者 通讯作者 12(11): https://doaj.org/article/3feae3bf3f434306a27008679c2ae64e.[24] Liu, Zengjin, Han, Huamin, He, Xin, Li, Shouwei, Wu, Chenxing, Yu, Chunjiang, Wang, Shengdian. Expression of the galectin-9-Tim-3 pathway in glioma tissues is associated with the clinical manifestations of glioma. ONCOLOGY LETTERS[J]. 2016, 第 7 作者 通讯作者 11(3): 1829-1834, https://www.webofscience.com/wos/woscc/full-record/WOS:000371634000034.[25] Yan, Zhongyi, Wu, Yahong, Du, Jiangfeng, Li, Guodong, Wang, Shengdian, Cao, Wenpeng, Zhou, Xiuman, Wu, Chunjing, Zhang, Dan, Jing, Xueli, Li, Yifan, Wang, Hongfei, Gao, Yanfeng, Qi, Yuanming. A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy. ONCOTARGET[J]. 2016, 第 5 作者7(26): 40437-40450, https://www.webofscience.com/wos/woscc/full-record/WOS:000378614700112.[26] Wang, Shengdian, Jia, Mingming, Zhang, S. Antibody Therapies in Cancer. PROGRESS IN CANCER IMMUNOTHERAPY[J]. 2016, 第 1 作者909: 1-67, https://www.webofscience.com/wos/woscc/full-record/WOS:000387463200002.[27] 王盛典. Expression of the galectin-9-Tim-3 pathway in glima tissues is associated with the clinical manifextations of glima. Oncology Letters. 2016, 第 1 作者 通讯作者 [28] Xu, Meng, Liu, Mingyue, Du, Xuexiang, Li, Sirui, Li, Hang, Li, Xiaozhu, Li, Ying, Wang, Yang, Qin, Zhihai, Fu, YangXin, Wang, Shengdian. Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 Phenotype. JOURNAL OF IMMUNOLOGY[J]. 2015, 第 11 作者 通讯作者 194(10): 4997-5006, https://www.webofscience.com/wos/woscc/full-record/WOS:000353728800041.[29] Wang, Fei, Yang, Li, Gao, Qun, Huang, Lan, Wang, Liping, Wang, Jing, Wang, Shengdian, Zhang, Bin, Zhang, Yi. CD163+CD14+macrophages, a potential immune biomarker for malignant pleural effusion. CANCER IMMUNOLOGY IMMUNOTHERAPY[J]. 2015, 第 7 作者64(8): 965-976, https://www.webofscience.com/wos/woscc/full-record/WOS:000358087400004.[30] Wang, Huiru, Sun, Qing, Wu, Yanhong, Wang, Lin, Zhou, Chunxia, Ma, Wenbo, Zhang, Youhui, Wang, Shengdian, Zhang, Shuren. Granzyme M expressed by tumor cells promotes chemoresistance and EMT in vitro and metastasis in vivo associated with STAT3 activation. ONCOTARGET[J]. 2015, 第 8 作者6(8): 5818-5831, https://www.webofscience.com/wos/woscc/full-record/WOS:000352793000025.[31] Chard, Louisa S, Maniati, Eleni, Wang, Pengju, Zhang, Zhongxian, Gao, Dongling, Wang, Jiwei, Cao, Fengyu, Ahmed, Jahangir, El Khouri, Margueritte, Hughes, Jonathan, Wang, Shengdian, Li, Xiaozhu, Denes, Bela, Fodor, Istvan, Hagemann, Thorsten, Lemoine, Nicholas R, Wang, Yaohe. A Vaccinia Virus Armed with Interleukin-10 Is a Promising Therapeutic Agent for Treatment of Murine Pancreatic Cancer. CLINICAL CANCER RESEARCH[J]. 2015, 第 11 作者21(2): 405-416, http://dx.doi.org/10.1158/1078-0432.CCR-14-0464.[32] Chen, Lin, Li, Jie, Zhang, Jinhua, Dai, Chengliang, Liu, Xiaoman, Wang, Jun, Gao, Zhitao, Guo, Hongyan, Wang, Rui, Lu, Shichun, Wang, Fusheng, Zhang, Henghui, Chen, Hongsong, Fan, Xiaolong, Wang, Shengdian, Qin, Zhihai. S100A4 promotes liver fibrosis via activation of hepatic stellate cells. JOURNAL OF HEPATOLOGY[J]. 2015, 第 15 作者62(1): 156-164, http://dx.doi.org/10.1016/j.jhep.2014.07.035.[33] 王盛典. Immunotherapy of metastatic and autochthonous liver cancer with IL-15/IL-15Ra fusion protein. OncoImmunology. 2014, 第 1 作者 通讯作者 [34] Cheng, Liang, Du, Xuexiang, Su, Lishan, Wang, Shengdian. Immunotherapy of metastatic and autochthonous liver cancer with IL-15/IL-15R alpha fusion protein. ONCOIMMUNOLOGY. 2014, 第 4 作者3(11): http://dx.doi.org/10.4161/21624011.2014.963409.[35] Ju JianQi, Jia MingMing, Cong YanNi, Wang ShengDian. Tumor Repression Mediated by IL-15 Expanded CD8 T Cell Correlated With Sustained Tumor-specific CD8 T Cells in Spleen. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS[J]. 2014, 第 4 作者 通讯作者 41(12): 1245-1254, https://www.webofscience.com/wos/woscc/full-record/WOS:000346818200007.[36] Cheng, Yushan, Liu, Chongdong, Zhang, Nawei, Wang, Shengdian, Zhang, Zhenyu. Proteomics Analysis for Finding Serum Markers of Ovarian Cancer. BIOMED RESEARCH INTERNATIONAL[J]. 2014, 第 4 作者2014: https://doaj.org/article/02bfd0fb97bf40cbae8b47eb4bee0484.[37] Wu, X, Zhang, H, Xing, Q, Cui, J, Li, J, Li, Y, Tan, Y, Wang, S. PD-1(+) CD8(+) T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients. BRITISH JOURNAL OF CANCER[J]. 2014, 111(7): 1391-1399, https://www.webofscience.com/wos/woscc/full-record/WOS:000343323100017.[38] Tan, Yi, Han, Xue, Wu, Xiaoran, Xing, Qiao, Chen, Lieping, Wang, Shengdian. Anti-TOSO antibody treatment promotes T cell activation-induced cell death (AICD) in vitro and in vivo. CHINESE SCIENCE BULLETIN[J]. 2014, 第 6 作者 通讯作者 59(13): 1374-1385, https://www.webofscience.com/wos/woscc/full-record/WOS:000333613100005.[39] Zhu, Lei, Chen, Yuxuan, Liu, Chongdong, Deng, Haiteng, Zhang, Nawei, Wang, Shengdian, Zhang, Zhenyu. Transthyretin as a novel candidate biomarker for preeclampsia. EXPERIMENTAL AND THERAPEUTIC MEDICINE[J]. 2014, 第 6 作者7(5): 1332-1336, https://www.webofscience.com/wos/woscc/full-record/WOS:000337557700048.[40] Cheng, Liang, Du, Xuexiang, Wang, Zheng, Ju, Jianqi, Jia, Mingming, Huang, Qibin, Xing, Qiao, Xu, Meng, Tan, Yi, Liu, Mingyue, Du, Peishuang, Su, Lishan, Wang, Shengdian. Hyper-IL-15 suppresses metastatic and autochthonous liver cancer by promoting tumour-specific CD8(+) T cell responses. JOURNAL OF HEPATOLOGY[J]. 2014, 第 13 作者61(6): 1297-1303, http://dx.doi.org/10.1016/j.jhep.2014.07.004.[41] Ju JianQi, Jia MingMing, Cong YanNi, Wang ShengDian. Tumor Repression Mediated by IL-15 Expanded CD8 T Cell Correlated With Sustained Tumor-specific CD8 T Cells in Spleen. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS[J]. 2014, 第 4 作者 通讯作者 41(12): 1245-1254, https://www.webofscience.com/wos/woscc/full-record/WOS:000346818200007.[42] 黄启彬, 刘明月, 符少月, 邢巧, 刘潇淇, 王盛典, 易发平. mIL-21-hIgGFc融合蛋白在293 E细胞中的表达纯化及其对CD8^+T细胞表型的影响. 中国免疫学杂志[J]. 2014, 第 6 作者30(7): 884-887,892, http://lib.cqvip.com/Qikan/Article/Detail?id=661813473.[43] Wu, Xiaoran, Tan, Yi, Xing, Qiao, Wang, Shengdian. IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation. PROTEIN & CELL[J]. 2013, 第 4 作者4(11): 863-871, https://www.webofscience.com/wos/woscc/full-record/WOS:000326939900008.[44] Li, Xinghui, Liu, Zhen, Yan, Xiaoli, Zhang, Xiaojun, Li, Yang, Zhao, Bao, Wang, Shengdian, Zhou, Xuyu, Gao, George F, Meng, Songdong. Induction of Regulatory T Cells by High-Dose gp96 Suppresses Murine Liver Immune Hyperactivation. PLOS ONE[J]. 2013, 第 7 作者8(7): https://doaj.org/article/17ebb4e46790479abee023d23227ea27.[45] Mortenson, Eric D, Park, SaeGwang, Jiang, Zhujun, Wang, Shengdian, Fu, YangXin. Effective Anti-Neu-Initiated Antitumor Responses Require the Complex Role of CD4(+) T Cells. CLINICAL CANCER RESEARCH[J]. 2013, 第 4 作者19(6): 1476-1486, http://dx.doi.org/10.1158/1078-0432.CCR-12-2522.[46] YANG YaJun, LI XiaoZhu, WANG YaoHe, WANG ShengDian. CD8^+ T cell response mediates the therapeutic effects of oncolytic adenovirus in an immunocompetent mouse model. 中国科学通报:英文版[J]. 2012, 第 4 作者57(1): 48-53, http://lib.cqvip.com/Qikan/Article/Detail?id=40772511.[47] Tysome, James R, Li, Xiaozhu, Wang, Shengdian, Wang, Pengju, Gao, Dongling, Du, Pan, Chen, Dong, Gangeswaran, Rathi, Chard, Louisa S, Yuan, Ming, Alusi, Ghassan, Lemoine, Nicholas R, Wang, Yaohe. A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity. CLINICAL CANCER RESEARCH[J]. 2012, 第 3 作者18(24): 6679-6689, http://www.irgrid.ac.cn/handle/1471x/756706.[48] 王盛典, 贾明明. 肿瘤免疫微环境在肿瘤常规治疗效应中的作用. 中国肿瘤生物治疗杂志[J]. 2012, 第 1 作者19(3): 229-238, http://lib.cqvip.com/Qikan/Article/Detail?id=42366859.[49] Xu, Meng, Du, Xuexiang, Liu, Mingyue, Li, Sirui, Li, Xiaozhu, Fu, YangXin, Wang, Shengdian. The tumor immunosuppressive microenvironment impairs the therapy of anti-HER2/neu antibody. PROTEIN & CELL[J]. 2012, 第 7 作者3(6): 441-449, http://www.irgrid.ac.cn/handle/1471x/756971.[50] Luan, Y, Ju, J, Luo, L, Zhang, Z, Wang, J, Zhu, D M, Cheng, L, Zhang, S Y, Chen, L, Wang, F S, Wang, S. Potential role of soluble B7-H3 in liver immunopathogenesis during chronic HBV infection. JOURNAL OF VIRAL HEPATITIS[J]. 2012, 19(1): 23-31, http://dx.doi.org/10.1111/j.1365-2893.2010.01421.x.[51] 王盛典. A Monoclonal Antibody Specific for the Programmed Death-1 Homolog Prevents Graft-versus-Host Disease in Mouse Models.. Journal of Immunology. 2012, 第 1 作者[52] Yang YaJun, Li XiaoZhu, Wang YaoHe, Wang ShengDian. CD8(+) T cell response mediates the therapeutic effects of oncolytic adenovirus in an immunocompetent mouse model. CHINESE SCIENCE BULLETIN[J]. 2012, 第 4 作者 通讯作者 57(1): 48-53, http://lib.cqvip.com/Qikan/Article/Detail?id=40772511.[53] Yang, Yajun, Li, Xiaozhu, Wang, Yaohe, Wang, Shengdian. CD8+T cell response mediates the therapeutic effects of oncolytic adenovirus in an immunocompetent mouse model. CANCER RESEARCH. 2012, 第 4 作者72: https://www.webofscience.com/wos/woscc/full-record/WOS:000209701500239.[54] Flies, Dallas B, Wang, Shengdian, Xu, Haiying, Chen, Lieping. Cutting Edge: A Monoclonal Antibody Specific for the Programmed Death-1 Homolog Prevents Graft-versus-Host Disease in Mouse Models. JOURNAL OF IMMUNOLOGY[J]. 2011, 第 2 作者187(4): 1537-1541, http://www.irgrid.ac.cn/handle/1471x/757459.[55] Liu, Yang, Wang, Shengdian, Wang, Fusheng, Li, Dongling, Zheng, Linghua, Zheng, Pan. Clusters of Differentiation 24 Polymorphism and Hepatocellular Carcinoma Reply. HEPATOLOGY. 2011, 第 2 作者54(6): 2273-2274, http://www.irgrid.ac.cn/handle/1471x/757558.[56] Han, Xue, Ye, Peiying, Luo, Liqun, Zheng, Linghua, Liu, Yang, Chen, Lieping, Wang, Shengdian. The development and functions of CD4(+) T cells expressing a transgenic TCR specific for an MHC-I-restricted tumor antigenic epitope. CELLULAR & MOLECULAR IMMUNOLOGY[J]. 2011, 第 7 作者 通讯作者 8(4): 333-340, http://www.irgrid.ac.cn/handle/1471x/757405.[57] 王盛典. B7-H2 is a costimulatory ligand for CD28 in human. Immunity. IMMUNITY. 2011, 第 1 作者 通讯作者 [58] Cheng, Liang, Wang, Jun, Li, Xiaozhu, Xing, Qiao, Du, Peishuang, Su, Lishan, Wang, Shengdian. Interleukin-6 Induces Gr-1+CD11b+Myeloid Cells to Suppress CD8+T Cell-Mediated Liver Injury in Mice. PLOS ONE[J]. 2011, 第 7 作者6(3): http://dx.doi.org/10.1371/journal.pone.0017631.[59] Wang, Shengdian, Chen, Lieping, Dranoff, G. Immunobiology of Cancer Therapies Targeting CD137 and B7-H1/PD-1 Cosignal Pathways. CANCER IMMUNOLOGY AND IMMUNOTHERAPY[J]. 2011, 第 1 作者344: 245-267, http://www.irgrid.ac.cn/handle/1471x/757561.[60] 王盛典. Interleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cells-mediated liver injury in mice. PLoS One. 2011, 第 1 作者 通讯作者 [61] 王盛典. Immunobiology of cancer therapies targeting CD137 and B7-H1/PD-1 cosignal athways. Current Topics in Microbiology and Immunology. 2011, 第 1 作者[62] Xue Han, Peiying Ye, Liqun Luo, Linghua Zheng, Yang Liu, Lieping Chen, Shengdian Wang. The development and functions of CD~4+ T cells expressing a transgenic TCR specific for an MHC-l-restricted tumor antigenic epitope. CELLULAR & MOLECULAR IMMUNOLOGY[J]. 2011, 第 7 作者8(4): 333-340, http://sciencechina.cn/gw.jsp?action=detail.jsp&internal_id=4274409&detailType=1.[63] Yao, Sheng, Zhu, Yuwen, Zhu, Gefeng, Augustine, Mathew, Zheng, Linghua, Goode, Diana J, Broadwater, Megan, Ruff, William, Flies, Sarah, Xu, Haiying, Flies, Dallas, Luo, Liqun, Wang, Shengdian, Chen, Lieping. B7-H2 Is a Costimulatory Ligand for CD28 in Human. IMMUNITY[J]. 2011, 第 13 作者34(5): 729-740, http://dx.doi.org/10.1016/j.immuni.2011.03.014.[64] Liang Cheng, Yunsheng Yang, Suping Ma, Dongling Li, Suyun Li, Mingzhou Guo, Wenxia Zhao, Yi Tan, Jun Wang, Xiaozhu Li, Shengdian Wang, Lieping Chen. CD137-Mediated Pathogenesis from Chronic Hepatitis to Hepatocellular Carcinoma in Hepatitis B Virus-Transgenic Mice. AMERICAN ASSOCIATION OF IMMUNOLOGISTS. 2010, 第 11 作者http://oa.las.ac.cn/oainone/service/browseall/read1?ptype=JA&workid=JA201902021923517ZK.[65] 程亮, 王盛典. 从动物模型看乙型病毒性肝炎致病机制的研究进展. 生命科学[J]. 2010, 第 2 作者338-344, http://lib.cqvip.com/Qikan/Article/Detail?id=33859756.[66] 王盛典. 从动物模型看乙型肝炎致病机制的研究进展.. 生命科学. 2010, 第 1 作者 通讯作者 [67] Wang, Jun, Zhao, Wenxia, Cheng, Liang, Guo, Mingzhou, Li, Dongling, Li, Xiaozhu, Tan, Yi, Ma, Suping, Li, Suyun, Yang, Yunsheng, Chen, Lieping, Wang, Shengdian. CD137-Mediated Pathogenesis from Chronic Hepatitis to Hepatocellular Carcinoma in Hepatitis B Virus-Transgenic Mice. JOURNAL OF IMMUNOLOGY[J]. 2010, 第 12 作者 通讯作者 185(12): 7654-7662, http://dx.doi.org/10.4049/jimmunol.1000927.[68] Wang ShengDian, Chen LiePing. Structural immunology of costimualtory and coinhibitory molecules. SCIENCE CHINA-LIFE SCIENCES[J]. 2010, 第 1 作者 通讯作者 53(2): 183-189, http://www.irgrid.ac.cn/handle/1471x/757276.[69] Park, SaeGwang, Jiang, Zhujun, Mortenson, Eric D, Deng, Liufu, RadkevichBrown, Olga, Yang, Xuanming, Sattar, Husain, Wang, Yang, Brown, Nicholas K, Greene, Mark, Liu, Yang, Tang, Jie, Wang, Shengdian, Fu, YangXin. The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity. CANCER CELL[J]. 2010, 第 13 作者 通讯作者 18(2): 160-170, http://dx.doi.org/10.1016/j.ccr.2010.06.014.[70] Li, Xiangqun, Han, Xue, Wang, Shengdian, Duan, Ziyuan. Development and Characterization of Monoclonal Antibodies Against Mouse TSLP. HYBRIDOMA[J]. 2010, 第 3 作者29(5): 425-430, http://www.irgrid.ac.cn/handle/1471x/757216.[71] Deng, Liufu, Zhang, Haizeng, Luan, Yan, Zhang, Jianfeng, Xing, Qiao, Dong, Shuxiao, Wu, Xiaoran, Liu, Mingyue, Wang, Shengdian. Accumulation of Foxp3(+) T Regulatory Cells in Draining Lymph Nodes Correlates with Disease Progression and Immune Suppression in Colorectal Cancer Patients. CLINICAL CANCER RESEARCH[J]. 2010, 第 9 作者 通讯作者 16(16): 4105-4112, http://dx.doi.org/10.1158/1078-0432.CCR-10-1073.[72] 王盛典. he Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity.. Cancer Cell. 2010, 第 1 作者 通讯作者 [73] Zheng, Linghua, Li, Dongling, Wang, Fusheng, Wu, Hao, Li, Xiaozhu, Fu, Junliang, Chen, Xinyue, Wang, Lizhong, Liu, Yang, Wang, Shengdian. Association Between Hepatitis B Viral Burden in Chronic Infection and a Functional Single Nucleotide Polymorphism of the PDCD1 Gene. JOURNAL OF CLINICAL IMMUNOLOGY[J]. 2010, 第 10 作者 通讯作者 30(6): 855-860, http://www.corc.org.cn/handle/1471x/2414542.[74] Yao, Sheng, Wang, Shengdian, Zhu, Yuwen, Luo, Liqun, Zhu, Gefeng, Flies, Sarah, Xu, Haiying, Ruff, William, Broadwater, Megan, Choi, InHak, Tamada, Koji, Chen, Lieping. PD-1 on dendritic cells impedes innate immunity against bacterial infection. BLOOD[J]. 2009, 第 2 作者113(23): 5811-5818, http://www.irgrid.ac.cn/handle/1471x/757838.[75] Li, Dongling, Zheng, Linghua, Jin, Lei, Zhou, Yuesu, Li, Haiying, Fu, Junliang, Shi, Ming, Du, Peishuang, Wang, Lizhong, Wu, Hao, Chen, GuoYun, Zheng, Pan, Liu, Yang, Wang, FuSheng, Wang, Shengdian. CD24 Polymorphisms Affect Risk and Progression of Chronic Hepatitis B Virus Infection. HEPATOLOGY[J]. 2009, 第 15 作者50(3): 735-742, http://www.irgrid.ac.cn/handle/1471x/757834.[76] Wang, Shengdian, Wang, Shengdian. Contribution of CD137 signaling to Hepatic Fibrosis via T cell and Macrophage Mediated Chronic Liver Inflammation. JOURNAL OF IMMUNOLOGY. 2009, 第 1 作者182: http://apps.webofknowledge.com/CitedFullRecord.do?product=UA&colName=WOS&SID=5CCFccWmJJRAuMzNPjj&search_mode=CitedFullRecord&isickref=WOS:000209763600344.[77] 刘书漫, 孟青, 张钦宪, 王盛典, 刘占举, 张谢夫. B7-H1及其受体PD-1在胃癌组织中的表达与意义. 中华肿瘤杂志[J]. 2008, 第 4 作者30(3): 192-195, http://lib.cqvip.com/Qikan/Article/Detail?id=26821190.[78] Wang, Shengdian, Chen, Lieping. T Lymphocyte Co-Signaling Pathways of the B7-CD28 Family. CELLULAR & MOLECULAR IMMUNOLOGY[J]. 2004, 第 1 作者1(1): 37-42, http://lib.cqvip.com/Qikan/Article/Detail?id=9686612.[79] Han Xue, Ye Peiying, Luo Liqun, Zheng Linghua, Liu Yang, Chen Lieping, Wang Shengdian. The development and functions of CD4 + T cells expressing a transgenic TCR specific for an MHC-I-restricted tumor antigenic epitope. CELLULAR AND MOLECULAR IMMUNOLOGY. 第 7 作者8(4): 333-340, http://www.irgrid.ac.cn/handle/1471x/757405.